報價延遲最少15分鐘:2024/12/24 12:45 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.15 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.26/0.05
|
|
企業價值
117.19M
|
| 資產負債 |
|
每股賬面淨值
0.05
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
50.16M
|
|
每股收益
3.85
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/12/24 12:45 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services. |